The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (15.70) USD. With the latest stock price at 14.88 USD, the upside of Neogenomics Inc based on DCF is -205.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.8% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (38.97) - (10.65) | (15.70) |
| Upside | -361.9% - -171.6% | -205.5% |